Home Jobs Physician Job Opportunity at Johnson & Johnson – Director, Medical Review Safety...

Physician Job Opportunity at Johnson & Johnson – Director, Medical Review Safety Physician (Oncology)

0
Explore this physician job at Johnson & Johnson as Director, Medical Review Safety Physician – Oncology. Discover qualifications, responsibilities, and MD jobs in the USA.
Physician Job at Johnson & Johnson – Oncology Director

Physician Job Opportunity at Johnson & Johnson | Apply Now

Looking for a high-level physician job in the pharmaceutical industry? Johnson & Johnson is hiring a Medical Review Safety Physician (Director, MRSP) – Oncology in the United States. This exciting opportunity under Johnson & Johnson careers allows experienced MD professionals to contribute to oncology pharmacovigilance, safety evaluation, and innovative medicine development while impacting global healthcare.

Job Details:

  • Job Position: Medical Review Safety Physician (Director, MRSP) – Oncology
  • Job Category: Distinguished Scientist, Product Safety Risk Management – MD (ST9)
  • Job ID: R-059996
  • Location: Horsham, Pennsylvania | Raritan, New Jersey | Titusville, New Jersey | United States of America
  • Application Deadline: March 15, 2026

About the Company:

Johnson & Johnson is a global leader in healthcare innovation. The company focuses on Innovative Medicine and MedTech to prevent, treat, and cure complex diseases. Guided by its Credo, Johnson & Johnson promotes diversity, inclusion, and respect while delivering science-based healthcare breakthroughs that improve lives worldwide. With a strong presence across the United States and globally, Johnson & Johnson continues to lead advancements in oncology, pharmaceuticals, and patient-centered healthcare solutions.

Job Description:

Johnson & Johnson is recruiting for a Director, Medical Review Safety Physician (MRSP) – Oncology. This senior-level physician job plays a critical role in evaluating safety data as part of the Pharmacovigilance process. The Director, MRSP is responsible for determining the medical and scientific relevance of adverse event reports within the context of the product’s safety profile and therapeutic area. Safety data sources include: Spontaneous reports, Clinical and non-clinical studies, Literature reports & Other pharmacovigilance sources. The role also includes participation in Safety Management Teams (SMTs) and providing pharmacovigilance expertise on individual case reports. Responsibilities extend to preparing aggregate safety reports such as PBRERs, Risk Management Plans, ad-hoc regulatory reports, and interpreting surveillance and product quality data. This position serves as a senior technical leader, supporting internal and external business initiatives within oncology safety.

Qualifications:

  • Physician (MD or equivalent)
  • Minimum 2 years of clinical medicine experience (preferred)
  • Board certification (US preferred)
  • Medical specialization preferred
  • Minimum 4 years of experience in industry, academia, or patient care
  • Direct pharmacovigilance experience strongly preferred
  • Knowledge of Good Clinical Practices (GCP) required
  • Excellent written and verbal communication skills
  • Strong analytical judgment to evaluate safety profiles across a large product portfolio

Key Responsibilities:

The Director, MRSP – Oncology will:

  • Analyze and assess SUSARs and Individual Case Safety Reports (ICSRs)
  • Evaluate Critical Cases (DME, EVOI, etc.)
  • Detect single case safety signals and provide recommendations
  • Participate in Signal Evaluation processes
  • Serve as a member of Safety Management Teams
  • Ensure follow-up of critical cases and Events of Special Interest
  • Contribute to PBRER/PADER activities
  • Support Investigator Brochure updates
  • Oversee vendor activities
  • Mentor new hires and Fellows
  • Conduct systematic reviews of aggregate safety data
  • Perform signal detection and validation
  • Prepare safety data summaries for PSRs/SMTs

CLICK HERE TO APPLY

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Exit mobile version